The approval makes GARDASIL the first HPV vaccine approved for use in males in China. GARDASIL is now indicated in China to prevent anal cancers caused by HPV Types 16 and 18, genital warts ...

In today's 3 O'Clock Drop, we discussed some of the performers we think should perform at the Super Bowl Halftime Show that ...

Archaeologists in Switzerland have uncovered the ruins of a Roman-era amphitheater — possibly the youngest on record — where ...

Kennedy Jr., President Trump’s nominee to run the Department of Health and Human Services, is giving away the fees that he could earn from litigation over Merck’s HPV vaccine Gardasil — to ...

Mr. Kennedy said that he had sent hundreds of clients to the firm, which is suing the drug maker Merck over claims that young people were injured by the company’s Gardasil vaccine, aimed at ...

Pokemon Legends: Z-A is likely to release between April and July, with possible post-launch support later in the year. Leaks hint at a new mainline Nintendo Switch 2 title in 2025, possibly Black ...

President Donald Trump’s pick for secretary of Health and Human Services said he will divest his interest in lawsuits against an HPV vaccine manufacturer. In written responses to questions from Sen.

Kennedy Jr. told lawmakers in response to questions released on Friday that he would divest his interest in litigation against a major HPV vaccine maker and would sign over the financial stake to ...

Following the announcement, several options have been listed on the official Pokemon Center website. All of these items are currently listed as unavailable, but should be made available for ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products Administration, becoming the first and only HPV vaccine authorized for use in men ...

During his time as a vaccine injury attorney, Kennedy launched complaints and lawsuits against Merck, the maker of Gardasil, which was first approved by the Food and Drug Administration in 2006.

The human papillomavirus (HPV) vaccine has long been a key player in reducing the risks associated with various cancers. However, recent research has further underscored its unprecedented ...